Morgan Stanley’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295 | Sell |
|
|||||
|
2025
Q1 | $610 | Sell |
|
|||||
|
2024
Q4 | $2.27K | Sell |
|
|||||
|
2024
Q3 | $1.89K | Hold |
|
|||||
|
2024
Q2 | $2.17K | Sell |
|
|||||
|
2024
Q1 | $5.44K | Sell |
|
|||||
|
2023
Q4 | $15.8K | Buy |
|
|||||
|
2023
Q3 | $9.71K | Sell |
|
|||||
|
2023
Q2 | $14.4K | Hold |
|
|||||
|
2023
Q1 | $7.61K | Buy |
|
|||||
|
2022
Q4 | $10.2K | Sell |
|
|||||
|
2022
Q3 | $18K | Buy |
|
|||||
|
2022
Q2 | $36K | Sell |
|
|||||
|
2022
Q1 | $95K | Sell |
|
|||||
|
2021
Q4 | $252K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1K | Buy |
|